We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
1401
Collegium Pharmaceutical
COLL
$956M
– –
-815
Closed -$16K
CRL icon
1402
Charles River Laboratories
CRL
$12.8B
– –
-1,539
Closed -$635K
CRNC icon
1403
Cerence
CRNC
$413M
– –
-16,020
Closed -$1.54M
CRNX icon
1404
Crinetics Pharmaceuticals
CRNX
$8.92B
– –
-885
Closed -$18K
CROX icon
1405
Crocs
CROX
$6.55B
– –
-9,377
Closed -$1.34M
CSIQ icon
1406
Canadian Solar
CSIQ
$1.08B
– –
-412
Closed -$14K
CSTL icon
1407
Castle Biosciences
CSTL
$979M
– –
-575
Closed -$38K
CTMX icon
1408
CytomX Therapeutics
CTMX
$754M
– –
-1,490
Closed -$7K
CYTK icon
1409
Cytokinetics
CYTK
$10.4B
– –
-1,910
Closed -$68K
DAC icon
1410
Danaos Corp
DAC
$2.56B
– –
-2,556
Closed -$209K
DAO
1411
Youdao
DAO
$2.19B
– –
-16,625
Closed -$200K
DECK icon
1412
Deckers Outdoor
DECK
$13.3B
– –
-82,494
Closed -$4.95M
DIOD icon
1413
Diodes
DIOD
$4.84B
– –
-2,115
Closed -$191K
DNTH icon
1414
Dianthus Therapeutics
DNTH
$6.09B
– –
-83
Closed -$9K
DOCS icon
1415
Doximity
DOCS
$4.88B
– –
-69,314
Closed -$5.59M
DTIL icon
1416
Precision BioSciences
DTIL
$207M
– –
-45
Closed -$15K
DVAX
1417
DELISTED
Dynavax Technologies
DVAX
– –
-544,158
Closed -$10.5M
EDIT icon
1418
Editas Medicine
EDIT
$442M
– –
-1,560
Closed -$64K
EFT
1419
Eaton Vance Floating-Rate Income Trust
EFT
$288M
– –
-652,388
Closed -$9.51M
ENTA icon
1420
Enanta Pharmaceuticals
ENTA
$400M
– –
-460
Closed -$26K
ESPR
1421
DELISTED
Esperion Therapeutics
ESPR
– –
-645
Closed -$7K
FATE icon
1422
Fate Therapeutics
FATE
$326M
– –
-2,180
Closed -$129K
KYNB
1423
Kyntra Bio
KYNB
$29.4M
– –
-85
Closed -$21K
FICO icon
1424
Fair Isaac
FICO
$22.5B
– –
-101
Closed -$40K
FOLD
1425
DELISTED
Amicus Therapeutics
FOLD
– –
-6,100
Closed -$58K
55 56
57
58 59

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.